| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5703176 | American Journal of Ophthalmology | 2017 | 30 Pages |
Abstract
The VA and SDOCT results compare favorably with outcomes seen in randomized controlled trials. The results suggest that good long-term outcomes can be achieved using aflibercept for nAMD in clinical settings.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Maria Eleftheriadou, Clara Vazquez-Alfageme, Cristina Maria Citu, Roxanne Crosby-Nwaobi, Sobha Sivaprasad, Philip Hykin, Robin D. Hamilton, Praveen J. Patel,